|
December 6, 2005 Categories: Blogroll Posted by admin
Biophan Technologies, Inc. (OTCBB: BIPH), a developer of next-generation medical technology, yesterday announced results from testing of the Company’s patented technology that will enable magnetic resonance imaging (MRI) within vascular stents, allowing physicians for the first time to assess the health of stented arteries by means of non-invasive MRI technology. Biophan CEO Michael Weiner made the announcement.
Full news
|
|
